Statistics

Total Visits

Views
Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab17

Select a period of time:

Number of views in the range

Views
Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab7

Views

Views
March 20241
April 20240
May 20244
June 20242
July 20240
August 20240
September 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
 

Top cities views

Views
Chicago2